EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Strongyloides Hyperinfection Treated with Subcutaneous Ivermectin in a Patient with an Inborn Error of Immunity

Peter Conlon, Fergal Howley, Dana Al Sharqi, Andrew Beverland, Fionnuala Cox, Aisling Brown, Eoghan de Barra

The American Journal of Tropical Medicine and Hygiene · 2025

DOI: 10.4269/ajtmh.25-0146 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Peter Conlon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Antiparasitic Agents, Common Variable Immunodeficiency, Ivermectin, Strongyloidiasis. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Strongyloides hyperinfection can be challenging to diagnose and treat. Although it is typically described in cases of secondary immunodeficiency, it has not previously been reported in a case of inborn error of immunity. Diagnosis via microscopy can be time-consuming and challenging, and serology results may be negative in the setting of hypogammaglobulinemia. Oral ivermectin is an effective treatment for strongyloidiasis and is commonly used in low-endemicity countries. However, its efficacy is limited in cases of malabsorption. Subcutaneous administration of ivermectin is widespread in veterinary medicine, but it is not licensed for use in humans. The use of subcutaneous ivermectin in the treatment of Strongyloides hyperinfection is described in a man with hypogammaglobulinemia secondary to common variable immune deficiency and associated severe malnutrition in the context of chronic Strongyloides -related malabsorption. The diagnostic challenges in low-endemicity settings and therapeutic considerations when oral therapy is unsuccessful are also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiparasitic AgentsCommon Variable ImmunodeficiencyIvermectinStrongyloidiasisAnimalsHumansAgammaglobulinemiaInjections, SubcutaneousStrongyloides stercoralis

Substanzen

Antiparasitic AgentsIvermectin

Autor:innen und Institutionen

  • Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland.
  • Department of Gastroenterology, Beaumont Hospital, Dublin, Ireland.
  • Department of Immunology, Beaumont Hospital, Dublin, Ireland.
  • Department of Infectious Diseases, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Department of International Health and Tropical Medicine, Royal College of Surgeons, Dublin, Ireland.

Zitieren

APA

Conlon, P., Howley, F., Al Sharqi, D., Beverland, A., Cox, F., Brown, A., & de Barra, E. (2025). Strongyloides Hyperinfection Treated with Subcutaneous Ivermectin in a Patient with an Inborn Error of Immunity. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0146

Vancouver

Conlon P, Howley F, Al Sharqi D, Beverland A, Cox F, Brown A, et al. Strongyloides Hyperinfection Treated with Subcutaneous Ivermectin in a Patient with an Inborn Error of Immunity. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.25-0146

BibTeX
@article{Conlon2025,
  author = {Conlon, Peter and Howley, Fergal and Al Sharqi, Dana and Beverland, Andrew and Cox, Fionnuala and Brown, Aisling and de Barra, Eoghan},
  title = {Strongyloides Hyperinfection Treated with Subcutaneous Ivermectin in a Patient with an Inborn Error of Immunity},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2025},
  doi = {10.4269/ajtmh.25-0146}
}
Kostenlos starten →